Early-pregnancy percent body fat in relation to preeclampsia risk in obese women




Objective


The purpose of this study was to identify differences of early-pregnancy body fat percentage and body mass index (BMI) between obese women that experienced preeclampsia and those who did not.


Study Design


We performed an analysis of the Prenatal Exposures and Preeclampsia Prevention 3 longitudinal cohort study of preeclampsia mechanisms in obese and overweight women. Women completed questionnaires regarding their health behaviors; had hematocrit level, weight and height, and waist and hip circumferences measured, and had resistance and reactance measured by bioelectric impedance analysis machine during the first, second, and third trimesters. Total body water, fat mass, and percent body fat were calculated with the use of pregnancy-specific formulas. Preeclampsia was assessed with the clinical definition and a research definition (clinical preeclampsia plus hyperuricemia). Logistic regression models were constructed to analyze early-pregnancy BMI and body fat percentage (measured at 10.2 ± 3.0 weeks of gestation) as predictors of preeclampsia outcomes.


Results


Three hundred seventy-three women were included in the analysis: 30 women had preeclampsia by clinical definition (8.0%), and 14 women had preeclampsia by the research definition (3.8%). There was no relationship between BMI and preeclampsia risk in obese women; however, body fat percentage was associated significantly with increased risk of both the clinical definition of preeclampsia and the research definition. In 239 obese women, a 1% increase in body fat was associated with approximately 12% increased odds of clinical preeclampsia and 24% increased risk of preeclampsia by the research definition.


Conclusion


Early-pregnancy body fat appears to be important in the pathophysiologic condition of preeclampsia in obese women.


Preeclampsia is a serious pregnancy complication that occurs in 5-8% of pregnancies in the United States and accounts for approximately 15% of all preterm births. Maternal prepregnancy obesity is one of the strongest potentially modifiable risk factors for preeclampsia. There is a dose-response relationship between prepregnancy body mass index (BMI) and the risk of a woman experiencing either mild or severe preeclampsia.


In this study, we hypothesized that the amount of body fat may help to determine which obese women will experience preeclampsia. Prepregnancy BMI has been used to define obesity, but BMI is not an optimal indicator of percent body fat in general and is even less reliable in pregnancy. Bioelectric impedance analysis (BIA) is an alternative evaluation of obesity. This approach allows the estimation of body fat in large populations noninvasively and has been recommended as an approach to the assessment of this variable in pregnant women. In this study, we used BIA to measure body fat in a large population of pregnant obese women and examined the relationship of first-trimester percent body fat to preeclampsia in obese women.


Materials and Methods


Study population


Samples were collected as part of the Prenatal Exposures and Preeclampsia Prevention 3 Study, a longitudinal cohort study of preeclampsia mechanisms in obese and overweight women that was approved by the University of Pittsburgh institutional review board; all women gave informed consent. Lean women were recruited in smaller numbers to compare any findings in overweight and obese women with and without preeclampsia to findings in normal weight women. Women with preexisting hypertension, diabetes mellitus, renal disease, other medical complications, or multiple gestations were excluded. Women were recruited in early pregnancy from the outpatient clinics of Magee-Womens Hospital in Pittsburgh, PA, and had body composition assessed by bioelectrical impedance in the first, second, and third trimesters (at approximately 10, 20, and 35 weeks of gestation). The outpatient clinics serve primarily low-income, uninsured, unmarried, black, or biracial women; 373 women had complete early-pregnancy (first trimester) data and were eligible for inclusion in this study.


Measurements


Women completed a questionnaire regarding their health behaviors, reproductive history, and demographic characteristics. Standing height and waist and hip circumferences were measured twice for accuracy, and the mean of the 2 values was used. Waist circumference was measured at the natural waist with the center of the navel as a physical landmark. Hip circumference was measured just below the bony prominence of the anterior superior iliac spine. Early pregnancy BMI was calculated from weight and height measurements at the first visit (at 10.3 ± 2.9 weeks of gestation).


Resistance and reactance were measured with a Quantum IV Bioelectrical Impedance Analyzer (RJL Systems, Clinton Township, MI). Measurements were taken with the patient lying supine with arms at a 30-degree angle from the body and with the legs not touching so as not to disrupt the electrical circuit. Electrodes were attached in a tetrapolar arrangement, with 2 electrodes on the dorsal surface of the right foot and 2 electrodes on the dorsal surface of the right hand, 1 proximally and 1 distally. The distal electrodes act as the generating electrodes that transmit a small, painless electrical current; the proximal electrodes receive the electric current and measure the voltage drop between the right hand and right foot.


Body composition calculations


BIA theory estimates total body water (TBW) based on the resistance and reactance measured by a BIA machine and the patient’s height, weight, abdominal circumference, and hematocrit level. TBW during pregnancy was calculated with the equation determined by Lukaski et al ( Table 1 ). TBW was then used to estimate the weight of body fat. We derived an equation for weight of fat mass at any gestational age based on the equations provided by van Raaij et al. Water content of fat free mass was calculated using two separate equations, one for 0 to 10 weeks of gestation and one for 10 to 40 weeks of gestation, that were derived from Figure 1 of van Raaij et al. These equations were validated against deuterium dilution spaces and underwater weighing.



Table 1

Body composition equations


































Variable Equation
Total body water, L TBW = 0.7*(height [cm] 2 /resistance) + 0.051*(abdominal circumference [cm]) − 0.069*(weight [kg]) − 0.029*(reactance) − 0.043*(hematocrit) + 2.833
Weight of fat mass, kg
10 wk W FM = W B − TBW/0.725
20 wk W FM = W B − TBW/0.732
30 wk W FM = W B − TBW/0.740
40 wk W FM = W B − TBW/0.750
Water content of fat-free mass, %
0-10 wk y = 0.724 + 0.0001*GA
0-40 wk y = 0.00000666*GA 2 + 0.0005*GA + 0.719

GA , gestational age; TBW , total body water; W B , bodyweight.

Sween. Percent body fat and preeclampsia risk. Am J Obstet Gynecol 2015 .


Hematocrit level was measured in blood samples that were obtained by venipuncture.


Preeclampsia definition


We used 2 definitions of preeclampsia. The first matches the current American College of Obstetrics and Gynecology definition when we began the study, in which a woman with previously normal blood pressure has a blood pressure ≥140 and/or ≥90 mm Hg after 20 weeks of gestation and proteinuria; we will refer to this as the “clinical definition” of preeclampsia in the results. In previous studies, we found that a research definition (adds to the American College of Obstetricians and Gynecologists clinical definition an increase of >30 systolic and/or >15 diastolic above blood pressure at <20 weeks of gestation and hyperuricemia that is defined as 1 standard deviation of uric acid concentration above the mean for gestational age) defines a more severe and homogeneous preeclampsia population. Thirty women in the study cohort met the American College of Obstetricians and Gynecologists criteria for “clinical preeclampsia” that was defined earlier; 14 of these women also met the more restrictive “research” definition.


Blood pressure was determined by the average of 5 pressures taken after hospital admission for delivery and before the administration of any medications that would alter blood pressure. Proteinuria was defined as >0.3 g of protein in a 24-hour urine collection, 2+ protein measured by dipstick in a random urine sample, a catheterized urine sample with 1+ protein, or a protein-creatinine ratio >0.3. A jury reviewed the abstracted medical records to determine that criteria for preeclampsia had been satisfied.


Statistical methods


Baseline data were described with the mean ± standard deviation for continuous variables and percentages for categoric variables in the total population and separately by preeclampsia status. Potential differences between women with normal pregnancies or with preeclampsia were evaluated with the use of t tests for continuous variables (equal variances unless otherwise called for; unequal variances test used where appropriate) and χ 2 tests for categoric differences (Fisher exact test in cases where expected cell counts were <5). This study focused on early pregnancy BMI and body fat percentage as predictors of preeclampsia outcomes; therefore, first-trimester measurements of BMI and body fat were used in all primary analyses. Body fat percentage was examined as a function of BMI; the Pearson correlation coefficient is presented to assess the linear relationship. Lacking sufficient sample size to test appropriately for interaction between BMI and percent body fat, we instead assessed the relationship between body fat and preeclampsia by testing for differences in percent body fat between women with preeclampsia and healthy control subjects within each of the World Health Organization BMI classifications using t tests (a test with unequal variance where appropriate). Logistic regression models were constructed to analyze BMI and body fat percentage as continuous variables and allow adjustment for a limited selection of potential confounders. Because the Prenatal Exposures and Preeclampsia Prevention 3 study was designed to compare obese women who did or did not experience preeclampsia, we initially limited our logistic regression models only to obese women. We also performed a secondary analysis that included all participants because of the surprisingly high rates of preeclampsia in the lean and overweight women (by the clinical definition, 7.69% of lean women and 6.31% of overweight women experienced preeclampsia). All statistical analyses were performed with SAS software (version 9.4; SAS Institute, Cary, NC); probability values < .05 were considered statistically significant.




Results


Study participants were aged 23.7 ± 4.1 years; 63% of them were black, and 20% of them were smokers ( Table 2 ). The average BMI was 33.1 ± 7.8 kg/m 2 ; by study design, most participants were overweight (22.0%) or obese (64.1%). Gestational diabetes mellitus was more common in women in the both clinical (6.9%) and research-definitions of preeclampsia (14.3%) than in those with no preeclampsia (3.5%). Mean gestational age at delivery was 39.5 ± 1.3 weeks (39.0 ± 1.3 weeks for the 30 women with clinical preeclampsia and 38.1 ± 1.7 weeks for the 14 women with research preeclampsia). There were no significant differences in the distribution of obesity metrics (BMI, waist circumference, waist-hip ratio, or body fat percentage) in the 30 women with clinical or the 14 women with research preeclampsia compared with the 343 normal pregnancies ( Table 2 ).



Table 2

Baseline characteristics of study participants


























































































































































Characteristic All (n = 373) No preeclampsia (n = 343) Clinical preeclampsia (n = 30) P value a Research preeclampsia (n = 14) P value b
Age, y 23.7 ± 4.1 23.7 ± 4.1 23.3 ± 4.8 .62 24.9 ± 6.3 .30
Race, %
White 35.2 35.1 36.7 .76 50.0 .65
Black 63.2 63.2 63.3 50.0
Other 1.6 1.8 0 0
Smoking, % 20.1 21.3 6.7 .05 0 .08
Gestational age at enrollment, wk 10.2 ± 3.0 10.3 ± 2.9 9.6 ± 3.1 .22 9.0 ± 2.8 .10
Gestational age at delivery, wk 39.5 ± 1.4 39.5 ± 1.3 39.0 ± 1.6 .05 38.1 ± 1.7 .01
Gestational diabetes mellitus, % 3.8 3.5 6.9 .35 14.3 .02
Body mass index
At enrollment, kg/m 2 33.1 ± 7.8 33.0 ± 7.7 33.4 ± 8.5 .79 34.8 ± 11.2 .40
Classification, %
Lean 13.9 14.0 13.3 .89 14.3 .35
Overweight 22.0 21.9 23.3 28.6
Obese 1 29.8 30.3 23.3 14.3
Obese 2 15.8 15.5 20.0 7.1
Obese 3 18.5 18.4 20.0 35.7
Waist circumference, mm 1003 ± 168 1002 ± 168 1011 ± 175 .78 1028 ± 206 .57
Waist-hip ratio 0.86 ± 0.07 0.86 ± 0.07 0.87 ± 0.08 .68 0.88 ± 0.07 .30
Body fat percentage 45.9 ± 10.2 45.8 ± 10.1 46.9 ± 11.3 .57 48.6 ± 12.5 .31

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 10, 2017 | Posted by in GYNECOLOGY | Comments Off on Early-pregnancy percent body fat in relation to preeclampsia risk in obese women

Full access? Get Clinical Tree

Get Clinical Tree app for offline access